https://www.nasdaq.com/press-release/agtc-to-participate-in-the-h.c.-wainwright-bioconnect-2022-conference-2022-01-04
https://www.nasdaq.com/press-release/agtc-appoints-biopharmaceutical-industry-leader-james-robinson-to-its-board-of
https://www.nasdaq.com/press-release/agtc-appoints-abraham-scaria-ph.d.-as-chief-science-officer-2021-11-16
https://www.nasdaq.com/press-release/agtc-presents-data-from-ongoing-phase-1-2-trial-of-agtc-501-at-upcoming-american
https://www.nasdaq.com/press-release/agtc-appoints-hope-doyley-gay-as-general-counsel-2021-11-11
https://www.nasdaq.com/press-release/agtc-to-participate-in-the-stifel-2021-virtual-healthcare-conference-2021-11-10
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-1
https://www.nasdaq.com/press-release/agtc-to-host-first-quarter-financial-results-conference-call-and-webcast-on-november
https://www.nasdaq.com/press-release/agtc-to-present-at-upcoming-dry-amd-therapeutic-development-summit-2021-10-19
https://www.nasdaq.com/press-release/agtc-announces-two-key-leadership-team-appointments-2021-10-14
https://www.nasdaq.com/press-release/agtc-to-present-at-upcoming-cell-gene-management-meeting-on-the-mesa-2021-10-12
https://www.nasdaq.com/press-release/agtc-clinical-trial-investigators-to-present-data-from-ongoing-xlrp-and-achromatopsia
https://www.nasdaq.com/press-release/agtc-to-present-at-the-2021-cantor-fitzgerald-virtual-global-healthcare-conference
https://www.nasdaq.com/press-release/agtc-provides-financial-results-for-the-fourth-quarter-and-year-ended-june-30-2021
https://www.nasdaq.com/press-release/agtc-to-host-fourth-quarter-and-2021-fiscal-year-end-financial-results-conference
https://www.nasdaq.com/press-release/agtc-to-participate-in-clinical-trials-in-rare-diseases-conference-panel-and-case
https://www.nasdaq.com/press-release/agtc-is-excited-to-announce-seasoned-healthcare-financial-and-operations-executive
https://www.nasdaq.com/press-release/agtc-to-present-at-the-h.c.-wainwright-23rd-annual-global-investment-conference-2021
https://www.nasdaq.com/press-release/agtc-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference-2021-09-02
https://www.nasdaq.com/press-release/greater-gift-agtc-and-2020-on-site-partner-to-honor-celebrate-clinical-trial
https://www.nasdaq.com/press-release/agtc-announces-sponsorship-of-achroma-corps-no-roadblocks-program-2021-08-19
https://www.nasdaq.com/press-release/agtc-appoints-ophthalmology-and-retinal-disease-specialist-and-industry-rd-veteran
https://www.nasdaq.com/press-release/agtc-to-participate-in-envision-virtual-conference-east-2021-panel-discussion-2021-08
https://www.nasdaq.com/press-release/agtc-to-participate-at-upcoming-investor-conferences-2021-08-02
https://www.nasdaq.com/press-release/agtc-to-host-virtual-rd-day-on-july-22-2021-2021-07-08
https://www.nasdaq.com/press-release/agtc-reports-12-month-data-from-its-ongoing-phase-1-2-achromatopsia-clinical-trials
https://www.nasdaq.com/press-release/agtc-to-host-conference-call-on-june-24-at-8%3a00-am-et-to-discuss-achromatopsia-12
https://www.nasdaq.com/press-release/agtc-to-present-at-american-optometric-associations-optometrys-meeting-2021-06-22
https://www.nasdaq.com/press-release/agtc-expands-leadership-team-with-appointment-of-key-regulatory-leader-2021-05-26
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-march-31-0
https://www.nasdaq.com/press-release/concept-companies-breaks-ground-on-expansion-for-agtc-in-alachuas-foundation-park
https://www.nasdaq.com/press-release/agtc-announces-expansion-of-manufacturing-and-analytics-capabilities-to-advance
https://www.nasdaq.com/press-release/agtc-to-host-third-quarter-financial-results-conference-call-and-webcast-on-may-17
https://www.nasdaq.com/press-release/agtc-reports-process-development-advances-for-manufacturing-its-xlrp-gene-therapy
https://www.nasdaq.com/press-release/agtc-reports-positive-12-month-data-from-highest-dose-groups-in-its-ongoing-xlrp
https://www.nasdaq.com/press-release/agtc-to-host-conference-call-on-may-6-at-8%3a00-am-et-to-discuss-xlrp-full-12-month
https://www.nasdaq.com/press-release/agtc-advances-in-aav-gene-therapy-manufacturing-to-be-presented-at-the-american
https://www.nasdaq.com/press-release/agtc-clinical-investigators-provide-encore-presentation-of-data-from-the-companys
https://www.nasdaq.com/press-release/agtc-announces-data-to-be-presented-from-the-ongoing-xlrp-and-achromatopsia-clinical
https://www.nasdaq.com/press-release/agtc-announces-departure-of-chief-scientific-officer-2021-04-26
https://www.nasdaq.com/press-release/agtc-licenses-promoter-technology-to-sparingvision-sas-2021-04-19
https://www.nasdaq.com/press-release/teamedon-and-agtc-announce-a-licensing-agreement-advancing-x-linked-retinoschisis
https://www.nasdaq.com/press-release/agtc-to-participate-in-upcoming-virtual-biotech-corporate-access-day-and-cell-and
https://www.nasdaq.com/press-release/agtc-announces-new-initiatives-to-enhance-the-patient-journey-in-its-xlrp-trials-2021
https://www.nasdaq.com/press-release/agtc-to-present-at-the-gene-therapy-patient-engagement-summit-held-virtually-march-24
https://www.nasdaq.com/press-release/agtc-to-present-at-upcoming-investor-conferences-2021-03-02
https://www.nasdaq.com/press-release/agtc-to-present-at-the-ois-gene-therapy-innovation-showcase-on-february-18-2021-2021
https://www.nasdaq.com/press-release/agtc-to-present-at-the-4th-annual-gene-therapy-for-rare-disorders-digital-event
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-december
https://www.nasdaq.com/press-release/agtc-executives-awarded-first-place-in-the-bioprocess-international-readers-choice
https://www.nasdaq.com/press-release/agtc-to-host-second-quarter-financial-results-conference-call-and-webcast-on-february
https://www.nasdaq.com/press-release/agtc-announces-pricing-of-public-offering-of-common-stock-and-warrants-2021-01-28
https://www.nasdaq.com/press-release/agtc-announces-proposed-public-offering-of-common-stock-and-warrants-2021-01-27
https://www.nasdaq.com/press-release/agtc-announces-first-reported-improvements-in-visual-sensitivity-for-achromatopsia
https://www.nasdaq.com/press-release/agtc-to-participate-in-the-h.c.-wainwright-bioconnect-2021-conference-2021-01-06
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-0
https://www.nasdaq.com/press-release/agtc-reports-additional-positive-data-from-its-phase-1-2-clinical-trial-in-patients
https://www.nasdaq.com/press-release/agtc-to-host-conference-call-on-november-11-at-8%3a00-am-et-to-discuss-xlrp-12-month
https://www.nasdaq.com/press-release/agtc-to-participate-in-cantor-fitzgerald-virtual-panel%3a-key-considerations-for-gene
https://www.nasdaq.com/press-release/agtc-to-present-at-upcoming-virtual-conferences-2020-10-08
https://www.nasdaq.com/press-release/agtc-joins-the-my-retina-trackerr-program-as-a-new-scientific-collaborator-2020-10-07
https://www.nasdaq.com/press-release/agtc-provides-trial-design-update-for-its-phase-2-3-xlrp-clinical-trial-new-data-on
https://www.nasdaq.com/press-release/agtc-to-participate-at-upcoming-virtual-investor-conferences-2020-09-03
https://www.nasdaq.com/press-release/agtc-to-host-management-update-on-september-9-at-8%3a00-am-et-to-discuss-planned-phase
https://www.nasdaq.com/press-release/agtc-announces-publication-of-preclinical-data-that-support-the-ongoing-clinical
https://www.nasdaq.com/press-release/agtc-formalizes-patient-advisory-council-to-provide-insights-and-guidance-on-patient
https://www.nasdaq.com/press-release/agtc-to-present-at-the-wedbush-pacgrow-virtual-healthcare-conference-on-august-11
https://www.nasdaq.com/press-release/agtc-announces-updated-development-plan-for-its-x-linked-retinitis-pigmentosa
https://www.nasdaq.com/press-release/agtc-set-to-join-russell-3000r-and-2000r-indexes-2020-06-24
https://www.nasdaq.com/press-release/agtc-announces-significant-productivity-and-quality-enhancement-to-its-proprietary
https://www.nasdaq.com/press-release/agtc-to-present-at-bmo-capital-markets-2020-prescriptions-for-success-healthcare
https://www.nasdaq.com/press-release/agtc-launches-nationwide-mobile-vision-testing-program-for-patients-enrolled-in-its
https://www.nasdaq.com/press-release/agtc-announces-publication-of-positive-preclinical-data-that-provides-foundational
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-march-31
https://www.nasdaq.com/press-release/agtc-to-host-third-quarter-financial-results-conference-call-and-webcast-on-may-13
https://www.nasdaq.com/press-release/agtc-announces-completion-of-enrollment-in-all-adult-dose-groups-of-its-ongoing-phase
https://www.nasdaq.com/press-release/agtc-announces-completion-of-enrollment-in-the-two-highest-dose-groups-of-its-ongoing
https://www.nasdaq.com/press-release/agtc-announces-pricing-of-%2432500000-public-offering-of-common-stock-2020-02-06
https://www.nasdaq.com/press-release/agtc-announces-proposed-public-offering-of-common-stock-2020-02-05
https://www.nasdaq.com/press-release/agtc-reports-encouraging-interim-six-month-data-from-the-dose-escalation-cohorts-of
https://www.nasdaq.com/press-release/agtc-to-host-conference-call-and-webcast-on-january-23-at-8%3a00-am-et-to-discuss
https://www.nasdaq.com/press-release/agtc-announces-agenda-for-rd-day-on-january-28-2020-in-new-york-2020-01-21
https://www.nasdaq.com/press-release/thinking-about-buying-stock-in-applied-genetic-technologies-canopy-growth-corp
https://www.nasdaq.com/press-release/agtc-reports-positive-six-month-data-from-its-ongoing-phase-1-2-clinical-trial-in-x
https://www.nasdaq.com/press-release/agtc-to-host-conference-call-and-webcast-on-january-9-at-8%3a00-am-et-to-discuss-x
https://www.nasdaq.com/press-release/agtc-announces-departure-of-chief-medical-officer-company-on-track-to-announce-xlrp
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-september
https://www.nasdaq.com/press-release/agtc-to-host-first-quarter-results-conference-call-and-webcast-on-november-12-2019
https://www.nasdaq.com/press-release/agtc-announces-stargardt-disease-as-its-second-preclinical-ophthalmology-program-and
https://www.nasdaq.com/press-release/agtc-presents-data-demonstrating-efficiency-of-its-aav-vectors-for-ocular-gene
https://www.nasdaq.com/press-release/agtc-announces-financial-results-and-business-update-for-the-fourth-quarter-and
https://www.nasdaq.com/press-release/agtc-to-present-at-upcoming-conferences-2019-09-25
